Kolexia
Soussy Claude
Biologie médicale
Hôpital Henri Mondor
Créteil, France
16 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections bactériennes Maladies transmissibles Pneumopathie infectieuse Dermatoses bactériennes Maladies urologiques Infections urinaires Infections des tissus mous Maladies d'origine alimentaire Infections à staphylocoques

Industries

Novex Pharma
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Antimicrobial resistance and infection control   30 mai 2018
Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study.
Diagnostic microbiology and infectious disease   17 juin 2015
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   01 mars 2012
EUCAST expert rules in antimicrobial susceptibility testing.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   25 novembre 2011
Bacterial hypermutation: clinical implications.
Journal of medical microbiology   24 février 2011
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
International journal of antimicrobial agents   04 février 2011
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   19 novembre 2010
Diagnosis and treatment of acute uncomplicated urethritis of men: guidelines from the French committee of infectious disease of the French association of urology (CIAFU).
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie   15 juillet 2010
Activity of doripenem against anaerobic bacteria.
Pathologie-biologie   26 mai 2010
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.
Archives of internal medicine   04 mai 2010